PROTECT MULTI AKTIENANLEIHE - PFIZER INC/ELI LILLY & CO/NOVO-NORDISK B PROTECT MULTI AKTIENANLEIHE - PFIZER INC/ELI LILLY & CO/NOVO-NORDISK B Share Price
Certificat
DE000VU7U0Z4
| Market Closed - Deutsche Boerse AG 11:31:00 10/05/2024 pm IST | ||
| 99.75 USD | -0.01% |
|
| Current month | +3.09% | ||
| 1 month | +2.90% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/24/10 | 99.75 | -0.01% | 0 |
| 09/24/09 | 99.76 | -0.04% | 0 |
| 08/24/08 | 99.8 | +0.22% | 0 |
| 07/24/07 | 99.58 | +0.49% | 0 |
| 06/24/06 | 99.09 | +0.62% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 10, 2024 at 11:31 pm IST
More quotesStatic data
| Product type | Aktienanleihen |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Vontobel
|
| WKN | VU7U0Z |
| ISIN | DE000VU7U0Z4 |
| Date issued | 30/05/2023 |
| Strike | 422.5 $ |
| Maturity | 30/05/2024 (18 Days) |
| Parity | 0.42 : 1 |
| Emission price | 100 $ |
| Emission volume | N/A |
| Settlement | Beides |
| Currency | USD |
Technical Indicators
| Highest since issue | 100.4 $ |
|---|---|
| Lowest since issue | 91.74 $ |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
760
USD
Average target price
850.4
USD
Spread / Average Target
+11.90%
- Stock Market
- Certificates
- Certificat
